Exploring the effects of combined CBD and THC (20:1) on sleep and brain activation in patients with insomnia disorder. Eligible participants undergo two overnight sleep studies receiving randomised active and placebo treatments. This study is being led by Professor Ron Grunstein. See here for more information.
Study site: Woolcock Institute of Medical Research, Glebe, NSW 2037
Exploring the effect of combined THC and CBD (1:1) on tics in patients with Tourette syndrome. Eligible participants will undergo two 8-week treatment periods receiving either active or placebo treatment. This study is being led by Dr Philip Mosley. See here for more information.
Study site: The Wesley Hospital, Coronation Dr, Auchenflower, QLD 4066